Your browser doesn't support javascript.
loading
Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma.
Ma, Heng; Feng, Peng-Hui; Yu, Shuang-Ni; Lu, Zhao-Hui; Yu, Qi; Chen, Jie.
  • Ma H; Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, China.
  • Feng PH; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, China.
  • Yu SN; Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, China.
  • Lu ZH; Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, China.
  • Yu Q; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, China. yuqi2008001@sina.com.
  • Chen J; Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, China. chenjie@pumch.cn.
BMC Cancer ; 22(1): 543, 2022 May 13.
Article en En | MEDLINE | ID: mdl-35562682
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Neoplasias Endometriales Tipo de estudio: Diagnostic_studies / Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Neoplasias Endometriales Tipo de estudio: Diagnostic_studies / Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article